PUBLISHED DATE : Jul 2023 | Pages : 305
Fill out your details & get your free sample
The Metabolomics Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
305 Pages
134 Tables
119 Charts
5 Regions
18 Countries
20 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 5.33 Billion |
| Market Size (2022) | USD 2.58 Billion |
| CAGR (2022-2028) | 12.84% |
| Base Year | 2022 |
| FORECAST YEAR | 2023-2028 |
| SEGMENTS BY | Technologies, Application, End-user, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Agilent Technologies, Bio-Rad Laboratories, Danaher, PerkinElmer, and Thermo Fisher Scientific |
The global metabolomics market was valued at USD 2.58 billion in 2022 and is expected to reach USD 5.33 billion by 2028, growing at a CAGR of 12.84%. Factors such as rising investments in drug discovery and advances in analytical technologies are expected to contribute to market growth. Moreover, the increasing adoption of biomarkers, the introduction of artificial intelligence and machine learning, and the growing use of metabolomics in cancer research are expected to drive the metabolomics market over the forecast period.
Metabolomics is an emerging field in researching and developing novel therapeutics, diagnostics, and personalized medicine. With the rise of precision and personalized medicine, metabolomics is set to become a crucial part of the healthcare industry. Metabolomics is a powerful tool for analyzing the chemical composition of cells, tissues, and biofluids and can offer insight into the physiological state of an organism. The metabolomics market is driven by the increasing demand for personalized healthcare, better drug discovery and development, and the increasing prevalence of chronic and degenerative diseases.
Metabolomics research can provide information about the effects of genetic alterations and environmental factors on a cellular level. Identifying metabolites and tracking their effects on cellular processes can help understand the underlying causes of diseases and their progression. Additionally, establishing metabolomic profiles of normal and diseased states can lead to early diagnosis and personalized treatments. Further, with the increasing demand for personalized healthcare and the development of new biomarkers, the metabolomics market is expected to witness further growth in the coming years. Companies should capitalize on new opportunities to stay ahead of the competition and ensure that their products and services meet their customers' needs.
Growing Demand for Metabolomics in Food Safety and Quality Control
Metabolomics is becoming an increasingly important tool for food safety and quality control due to its ability to analyze the chemicals produced by organisms as they interact with their environment. Metabolomics allows researchers and producers to assess food's chemical composition, enabling them to detect potentially harmful substances and monitor the overall quality of food. Such factors are projected to affect the metabolomics market growth positively. Metabolomics can also identify adulterated foods, diagnose food-related illnesses, and determine the chemical composition of food-processing by-products. All of these uses can help producers provide consumers with safer and higher-quality food products and help ensure compliance with food safety regulations.
Increasing Funding for Metabolomics Research
Increasing funding for metabolomics research would allow researchers to explore further the biochemical processes occurring in organisms. Metabolomics studies the comprehensive view of all the molecules, or metabolites, in the body, which provides an in-depth understanding of the metabolic networks involved in diverse physiological and pathological conditions. More resources allocated to this field of research would enable scientists to understand better the connections between molecular events and their effects on an organism’s health. Research studies may also identify novel biomarkers that target specific aspects of metabolism, potentially aiding in developing more effective diagnostics for diseases and other conditions. Additionally, increased investment in metabolomics could facilitate the discovery of new drug targets and lead to the development of drugs with fewer side effects. The implications of research in this field can lead to a better understanding of the metabolic pathways in humans and other organisms and ultimately provide more personalized and effective treatments.
Growing Rate of Target Diseases
Metabolomics is a rapidly growing field of research that is being applied to studying various diseases, including cancer, diabetes, obesity, heart disease, Alzheimer's disease, and Parkinson's disease. By studying the different metabolites in an individual's body, researchers can gain valuable insight into the biochemical processes and potential causes of a wide range of diseases. The metabolomics market has paved the way to provide a better understanding of the molecular pathways and biochemical processes involved in the progression of a particular disease. By studying the metabolic pathways of a given disease, it may be possible to identify potential targets for therapeutic interventions.
INSIGHTS BY TECHNOLOGIES
The detection method technologies segment dominated the global metabolomics market, with a share of over 44% in 2022. Metabolomics is a powerful tool in biology and biochemistry, providing insights into the body’s metabolic and physiological processes. Over the last decade, technological advances have made metabolomics increasingly accessible and powerful. One important technology used in metabolomics is mass spectrometry. Mass spectrometry involves passing an ionized sample through a vacuum chamber, where it is broken down into its component elements. These mass spectra can then be used to identify and quantify the different metabolites present in a sample. Mass spectrometry is used in metabolomics to analyze complex metabolic mixtures and to determine the concentration of various metabolites in a sample.
INSIGHTS BY APPLICATION
The global metabolomics market by application is segmented into medical & clinical research, plant & food science, and biotechnology. Metabolomics is an ever-growing field of research that is gaining increasing attention due to its potential in medical and clinical applications. The medical and clinical applications of metabolomics are numerous. They can be used to diagnose and monitor diseases and study the effects of drugs, toxins, and other environmental factors on health. Metabolomics can provide insight into the molecular basis of diseases and the mechanisms of the action of drugs. This information can be used to improve drug design and to identify novel therapeutic targets. Metabolomics can also be used to predict drug response in individuals and to identify biomarkers that can be used to evaluate health status. Such factors have helped the medical & clinical research application segment to dominate the global metabolomics market during the forecast period.
INSIGHTS BY END-USER
The standalone metabolomics service providers segment accounted for the largest global metabolomics market share in 2022. Metabolomics service providers are becoming increasingly important in the field of research. By offering specialized services, such as sample preparation and analysis, data analysis and interpretation, and metabolite identification and quantification, these companies are helping researchers better understand how cells work and how diseases develop. As the demand for metabolomics services continues to grow, more companies are entering the market and offering specialized services to meet the needs of researchers.
North America dominated the global metabolomics market share, accounting for over 40% in 2022, mainly due to the developed infrastructure, increased government projects based on various new biological compound syntheses, advances in metabolomics technologies, and many research laboratories performing studies on various diseases. Metabolomics also has a wide range of applications other than healthcare, such as plant & food science, biofuel, and bioengineering. The most important factor that drives the regional market is the rise in investments in metabolomics. The major contributors in North America are the U.S. and Canada. Arizton predicts that the market in this region will grow at a healthy rate and dominate the global metabolomics market during the forecast period.
In Europe, the metabolomics market is expected to grow steadily due to the region's increasing demand for biomarkers and diagnostics. Countries such as Germany, the UK, France, Italy, and Spain are the major contributors to the European metabolomics market. Furthermore, Latin America and, the Middle East & Africa region are showing a growing focus on precision medicine adoption; also, there is an increase in its research, thus, fuelling the growth of the metabolomics market in these regions.
The global metabolomics market is highly competitive and dynamic due to several international, regional, and local players offering comprehensive metabolomics solutions. Rapid technological changes, frequent new product launches, and changes in industry standards characterize the market. Several companies are compelled to invest in new product development and product enhancement initiatives based on recent technological innovations so that their products are not rendered obsolete over time. Pharmaceutical companies, research and diagnostic laboratories, and healthcare establishments use metabolomics products. Launching more efficient and economical products will result in faster adoption and revolutionize the market.
Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are major global metabolomics market players offering metabolomics products. The key global players focus on developing innovative technologies or methods and expanding their product portfolio through acquisitions to remain competitive. Also, most players in the global metabolomics market are continuously investing extensively in R&D and product development initiatives to expand their product portfolio and ensure a sustainable presence in the highly competitive environment.
Frequently Asked Questions
How big is the metabolomics market?
The global metabolomics market size was valued at USD 2.58 billion in 2022 and is expected to reach 5.33 billion by 2028.
What is the growth rate of the metabolomics market?
The global metabolomics market is growing at a CAGR of 12.84% from 2022-2028.
What are the rising trends in the metabolomics market?
The rising trends in the metabolomics industry are the growing interest for metabolomics in plant & environmental studies, growing demand for metabolomics in food safety and quality control, and increasing funding for metabolomics research.
Which region holds the most significant global metabolomics market share?
North America dominated the global metabolomics market share in 2022, accounting for over 40%.
Who are the key players in the global metabolomics market?
Agilent Technologies, Bio-Rad Laboratories, Danaher, PerkinElmer, and Thermo Fisher Scientific are the key players in the vital global metabolomics market.
The global metabolomics market is expected to grow at a CAGR of approximately 12.84% from 2022 to 2028.
The following factors are likely to contribute to the growth of the metabolomics market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the metabolomics market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Metabolomics Service Providers
Segmentation by Technologies
Segmentation by Application
Segmentation by End-user
Segmentation By Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TECHNOLOGY
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
6.1.1 GEOGRAPHY SEGMENTATION INSIGHTS
6.1.2 TECHNOLOGY SEGMENTATION INSIGHTS
6.1.3 APPLICATION SEGMENTATION INSIGHTS
6.1.4 END-USER SEGMENTATION INSIGHTS
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 METABOLOMICS IN PLANT & ENVIRONMENTAL STUDIES
9.2 DEMAND FOR METABOLOMICS IN FOOD SAFETY & QUALITY CONTROL
9.3 INCREASED FUNDING FOR METABOLOMICS RESEARCH
10 MARKET GROWTH ENABLERS
10.1 APPLICATION OF METABOLOMICS IN PRECISION MEDICINE
10.2 INCREASED RATE OF TARGET DISEASES
10.3 DEMAND FOR METABOLOMICS IN DRUG DEVELOPMENT
11 MARKET RESTRAINTS
11.1 COMPLEXITY & DIVERSITY OF BIOLOGICAL SAMPLES
11.2 HIGH COST OF TOOLS & INSTRUMENTS
11.3 ISSUES RELATED TO EXAMINATION & DATA PROCESSING
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 MARKET OPPORTUNITIES
12.3.1 MARKET BY GEOGRAPHY
12.3.2 MARKET BY TECHNOLOGY
12.3.3 MARKET BY APPLICATION
12.3.4 MARKET BY END-USER
12.4 FIVE FORCES ANALYSIS
12.4.1 THREAT OF NEW ENTRANTS
12.4.2 BARGAINING POWER OF SUPPLIERS
12.4.3 BARGAINING POWER OF BUYERS
12.4.4 THREAT OF SUBSTITUTES
12.4.5 COMPETITIVE RIVALRY
13 TECHNOLOGY
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 DETECTION METHODS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 DETECTION METHODS BY GEOGRAPHY
13.4 SEPARATION METHODS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 SEPARATIONS METHOD BY GEOGRAPHY
13.5 BIOINFORMATICS TOOLS & SERVICES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 BIOINFORMATICS TOOLS & SERVICES BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 MEDICAL & CLINICAL RESEARCH
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MEDICAL & CLINICAL RESEARCH BY GEOGRAPHY
14.4 PLANT & FOOD SCIENCE
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 PLANT & FOOD SCIENCE BY GEOGRAPHY
14.5 BIOTECHNOLOGY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 BIOTECHNOLOGY BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 STANDALONE METABOLOMICS SERVICE PROVIDERS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 STANDALONE METABOLOMICS SERVICE PROVIDERS BY GEOGRAPHY
15.4 PHARMA & BIOTECH COMPANIES
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 PHARMA & BIOTECH COMPANIES BY GEOGRAPHY
15.5 RESEARCH & CLINICAL LABORATORIES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 RESEARCH & CLINICAL LABORATORIES BY GEOGRAPHY
15.6 OTHERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 OTHERS BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 NORTH AMERICA MARKET BY TECHNOLOGY
17.2.2 NORTH AMERICA MARKET BY APPLICATION
17.2.3 NORTH AMERICA MARKET BY END-USER
17.3 KEY COUNTRIES
17.3.1 US: MARKET SIZE & FORECAST
17.3.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 EUROPE MARKET BY TECHNOLOGY
18.2.2 EUROPE MARKET BY APPLICATION
18.2.3 EUROPE MARKET BY END-USER
18.3 KEY COUNTRIES
18.3.1 GERMANY: MARKET SIZE & FORECAST
18.3.2 FRANCE: MARKET SIZE & FORECAST
18.3.3 UK: MARKET SIZE & FORECAST
18.3.4 ITALY: MARKET SIZE & FORECAST
18.3.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 APAC MARKET BY TECHNOLOGY
19.2.2 APAC MARKET BY APPLICATION
19.2.3 APAC MARKET BY END-USER
19.3 KEY COUNTRIES
19.3.1 CHINA: MARKET SIZE & FORECAST
19.3.2 JAPAN: MARKET SIZE & FORECAST
19.3.3 INDIA: MARKET SIZE & FORECAST
19.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.3.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 LATIN AMERICA MARKET BY TECHNOLOGY
20.2.2 LATIN AMERICA MARKET BY APPLICATION
20.2.3 LATIN AMERICA MARKET BY END-USER
20.3 KEY COUNTRIES
20.3.1 BRAZIL: MARKET SIZE & FORECAST
20.3.2 MEXICO: MARKET SIZE & FORECAST
20.3.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
21.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
21.2.3 MIDDLE EAST & AFRICA MARKET BY END-USER
21.3 KEY COUNTRIES
21.3.1 TURKEY: MARKET SIZE & FORECAST
21.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
21.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 AGILENT TECHNOLOGIES
22.2.2 BIO-RAD LABORATORIES
22.2.3 DANAHER
22.2.4 PERKINELMER
22.2.5 THERMO FISHER SCIENTIFIC
23 KEY COMPANY PROFILES
23.1 AGILENT TECHNOLOGIES
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 BIO-RAD LABORATORIES
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 DANAHER
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 PERKINELMER
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 THERMO FISHER SCIENTIFIC
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 ADVION
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 BGI
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 BIOCRATES LIFE SCIENCES
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 BRUKER
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 LECO
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 MERCK KGAA
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 SCION INSTRUMENTS
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 SHIMADZU CORPORATION
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 WATERS
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
25 METABOLOMICS SERVICE PROVIDERS
25.1 CREATIVE PROTEOMICS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 HUMAN METABOLOME TECHNOLOGIES
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 METABOLON
25.3.1 BUSINESS OVERVIEW
25.3.2 SERVICE OFFERINGS
25.4 METWARE BIOTECHNOLOGY
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 MS-OMICS
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 VPROTEOMICS
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY TECHNOLOGY
27.1.1 NORTH AMERICA MARKET BY TECHNOLOGY
27.1.2 EUROPE MARKET BY TECHNOLOGY
27.1.3 APAC MARKET BY TECHNOLOGY
27.1.4 LATIN AMERICA MARKET BY TECHNOLOGY
27.1.5 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
27.2 MARKET BY APPLICATION
27.2.1 NORTH AMERICA MARKET BY APPLICATION
27.2.2 EUROPE MARKET BY APPLICATION
27.2.3 APAC MARKET BY APPLICATION
27.2.4 LATIN AMERICA MARKET BY APPLICATION
27.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
27.3 MARKET BY END-USER
27.3.1 NORTH AMERICA MARKET BY END-USER
27.3.2 EUROPE MARKET BY END-USER
27.3.3 APAC MARKET BY END-USER
27.3.4 LATIN AMERICA MARKET BY END-USER
27.3.5 MIDDLE EAST & AFRICA MARKET BY END-USER
27.4 MARKET BY GEOGRAPHY
27.4.1 DETECTION METHODS BY GEOGRAPHY
27.4.2 SEPARATION METHODS BY GEOGRAPHY
27.4.3 BIOINFORMATICS TOOLS & SERVICES BY GEOGRAPHY
27.4.4 MEDICAL & CLINICAL RESEARCH BY GEOGRAPHY
27.4.5 PLANT & FOOD SCIENCE BY GEOGRAPHY
27.4.6 BIOTECHNOLOGY BY GEOGRAPHY
27.4.7 STANDALONE METABOLOMICS SERVICE PROVIDERS BY GEOGRAPHY
27.4.8 PHARMA & BIOTECH COMPANIES BY GEOGRAPHY
27.4.9 RESEARCH & CLINICAL LABORATORIES BY GEOGRAPHY
27.4.10 OTHERS BY GEOGRAPHY
28 APPENDIX
28.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL METABOLOMICS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY: MARKET SHARE 2022 & 2028 (%)
EXHIBIT 4 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY: MARKET SHARE 2022 & 2028 (%)
EXHIBIT 5 GLOBAL METABOLOMICS MARKET BY APPLICATION: MARKET SHARE 2022 & 2028 (%)
EXHIBIT 6 GLOBAL METABOLOMICS MARKET BY END-USER: MARKET SHARE 2022 & 2028 (%)
EXHIBIT 7 APPLICATION AREAS OF METABOLOMICS
EXHIBIT 8 IMPACT OF METABOLOMICS IN PLANT & ENVIRONMENTAL STUDIES
EXHIBIT 9 UNTARGETED & TARGETED APPROACHES FOR METABOLOMIC ANALYSIS IN PLANTS
EXHIBIT 10 IMPACT OF DEMAND FOR METABOLOMICS IN FOOD SAFETY & QUALITY CONTROL
EXHIBIT 11 IMPACT OF INCREASED FUNDING FOR METABOLOMICS RESEARCH
EXHIBIT 12 IMPACT OF APPLICATION OF METABOLOMICS IN PRECISION MEDICINE
EXHIBIT 13 MULTI-OMICS APPROACHES OF RESEARCH DATA FOR PERSONALIZED MEDICINE
EXHIBIT 14 IMPACT OF INCREASED RATE OF TARGET DISEASES
EXHIBIT 15 IMPACT OF DEMAND FOR METABOLOMICS IN DRUG DEVELOPMENT
EXHIBIT 16 ROLE OF METABOLOMICS IN EARLY DRUG DEVELOPMENT
EXHIBIT 17 IMPACT OF COMPLEXITY & DIVERSITY OF BIOLOGICAL SAMPLES
EXHIBIT 18 IMPACT OF HIGH COST OF TOOLS & INSTRUMENTS
EXHIBIT 19 IMPACT OF ISSUES RELATED TO EXAMINATION & DATA PROCESSING
EXHIBIT 20 GLOBAL METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 21 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
EXHIBIT 22 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
EXHIBIT 23 GLOBAL METABOLOMICS MARKET BY APPLICATION: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
EXHIBIT 24 GLOBAL METABOLOMICS MARKET BY END-USER: MARKET OPPORTUNITY OVERVIEW ($ MILLION)
EXHIBIT 25 FIVE FORCES ANALYSIS 2022
EXHIBIT 26 INCREMENTAL GROWTH BY TECHNOLOGY 2022 & 2028
EXHIBIT 27 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 28 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY: ABSOLUTE GROWTH (%)
EXHIBIT 29 GLOBAL DETECTION METHOD METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 30 GLOBAL DETECTION METHODS METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 31 GLOBAL SEPARATION METHODS METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 32 GLOBAL SEPARATION METHODS METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 33 GLOBAL BIOINFORMATICS TOOLS & SERVICES METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL BIOINFORMATICS TOOLS & SERVICES METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028
EXHIBIT 36 GLOBAL METABOLOMICS MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLIONS)
EXHIBIT 37 GLOBAL METABOLOMICS MARKET BY APPLICATION: ABSOLUTE GROWTH (%)
EXHIBIT 38 GLOBAL MEDICAL & CLINICAL RESEARCH METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL MEDICAL & CLINICAL RESEARCH METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 40 GLOBAL PLANT & FOOD SCIENCE METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL PLANT & FOOD SCIENCE METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 42 GLOBAL BIOTECHNOLOGY METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL BIOTECHNOLOGY METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY END-USER 2022 & 2028
EXHIBIT 45 GLOBAL METABOLOMICS MARKET BY END-USER: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 46 GLOBAL METABOLOMICS MARKET BY END-USER: ABSOLUTE GROWTH (%)
EXHIBIT 47 GLOBAL STANDALONE METABOLOMICS SERVICE PROVIDERS METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL STANDALONE METABOLOMICS SERVICE PROVIDERS METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 49 GLOBAL PHARMA & BIOTECH COMPANIES METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL PHARMA & BIOTECH COMPANIES METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 51 GLOBAL RESEARCH & CLINICAL LABORATORIES METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL RESEARCH & CLINICAL LABORATORIES METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 53 GLOBAL OTHERS METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL OTHERS METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 55 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 56 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 57 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 58 NORTH AMERICA METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 NORTH AMERICA METABOLOMICS MARKET: KEY COUNTRIES 2022 ($ MILLION)
EXHIBIT 60 NORTH AMERICA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 61 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 62 PERSONALIZED MEDICINES WITH SPECIFIC BIOMARKERS: TOP 20% OF FDA APPROVALS BETWEEN 2005 & 2019
EXHIBIT 63 US METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 64 CANADA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 65 EUROPE METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 66 EUROPE METABOLOMICS MARKET: KEY COUNTRIES 2022 ($ MILLION)
EXHIBIT 67 EUROPE METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 69 GERMANY METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 70 FRANCE METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 71 UK METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 72 ITALY METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 73 SPAIN METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 74 APAC METABOLOMICS MARKET: KEY COUNTRIES 2022 ($ MILLION)
EXHIBIT 75 APAC METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 APAC METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 77 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 78 CHINA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 79 JAPAN METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 80 INDIA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 81 SOUTH KOREA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 82 AUSTRALIA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 83 LATIN AMERICA METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 84 LATIN AMERICA METABOLOMICS MARKET: KEY COUNTRIES 2022 ($ MILLION)
EXHIBIT 85 LATIN AMERICA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 86 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 87 BRAZIL METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 88 MEXICO METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 89 ARGENTINA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 90 MIDDLE EAST & AFRICA METABOLOMICS MARKET: KEY COUNTRIES 2022 ($ MILLION)
EXHIBIT 91 MIDDLE EAST & AFRICA METABOLOMICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 92 MIDDLE EAST & AFRICA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 93 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 94 TURKEY METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 95 SOUTH AFRICA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 96 SAUDI ARABIA METABOLOMICS MARKET 2022–2028 ($ MILLION)
EXHIBIT 97 VENDORS' OUTLOOK IN GLOBAL METABOLOMICS MARKET
EXHIBIT 98 VENDORS THAT OFFER COMMERCIAL METABOLOMICS PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 99 VENDORS THAT OFFER COMMERCIAL METABOLOMICS PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 100 AGILENT TECHNOLOGIES: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 101 AGILENT TECHNOLOGIES: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 102 AGILENT TECHNOLOGIES: REVENUE BY BUSINESS SEGMENT 2020–2022 ($ BILLION)
EXHIBIT 103 AGILENT TECHNOLOGIES: REVENUE BY GEOGRAPHY 2020–2022 ($ BILLION)
EXHIBIT 104 BIO-RAD LABORATORIES: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 105 BIO-RAD LABORATORIES: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 106 BIO-RAD LABORATORIES: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 107 BIO-RAD LABORATORIES: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
EXHIBIT 108 DANAHER: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 109 DANAHER: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 110 DANAHER: REVENUE BY BUSINESS SEGMENT 2020–2022 ($ BILLION)
EXHIBIT 111 DANAHER: REVENUE BY GEOGRAPHIC REGION 2020–2022 ($ BILLION)
EXHIBIT 112 PERKINELMER: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 113 PERKINELMER: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 114 PERKINELMER: REVENUE BY BUSINESS SEGMENT 2020–2022 ($ BILLION)
EXHIBIT 115 PERKINELMER: REVENUE BY GEOGRAPHIC REGION 2020–2022 ($ BILLION)
EXHIBIT 116 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 117 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 118 THERMO FISHER SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020–2022 ($ BILLION)
EXHIBIT 119 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHIC REGION 2020–2022 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2016–2022
TABLE 3 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY: MARKET SIZE 2022–2028 ($ MILLION)
TABLE 4 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY: MARKET SIZE 2022–2028 ($ MILLION)
TABLE 5 GLOBAL METABOLOMICS MARKET BY APPLICATION: MARKET SIZE 2022–2028 ($ MILLION)
TABLE 6 GLOBAL METABOLOMICS MARKET BY END-USER: MARKET SIZE 2022–2028 ($ MILLION)
TABLE 7 GLOBAL DETECTION METHODS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 8 GLOBAL DETECTION METHODS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 9 GLOBAL SEPARATIONS METHOD METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 10 GLOBAL SEPARATIONS METHOD METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 11 GLOBAL BIOINFORMATICS TOOLS & SERVICES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 12 GLOBAL BIOINFORMATICS TOOLS & SERVICES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 13 GLOBAL MEDICAL & CLINICAL RESEARCH METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 14 GLOBAL MEDICAL & CLINICAL RESEARCH METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 15 GLOBAL PLANT & FOOD SCIENCE METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 16 GLOBAL PLANT & FOOD SCIENCE METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 17 GLOBAL BIOTECHNOLOGY METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 18 GLOBAL BIOTECHNOLOGY METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 19 GLOBAL STANDALONE METABOLOMICS SERVICE PROVIDERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 20 GLOBAL STANDALONE METABOLOMICS SERVICE PROVIDERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 21 GLOBAL PHARMA & BIOTECH COMPANIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 22 GLOBAL PHARMA & BIOTECH COMPANIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 23 GLOBAL RESEARCH & CLINICAL LABORATORIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 24 GLOBAL RESEARCH & CLINICAL LABORATORIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 25 GLOBAL OTHERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 26 GLOBAL OTHERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 27 NORTH AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 28 NORTH AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 29 NORTH AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 30 NORTH AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 31 NORTH AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 32 NORTH AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 33 EUROPE METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 34 EUROPE METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 35 EUROPE METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 36 EUROPE METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 37 EUROPEAN METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 38 EUROPEAN METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 39 APAC METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 40 APAC METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 41 APAC METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 42 APAC METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 43 APAC METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 44 APAC METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 45 LATIN AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 46 LATIN AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 47 LATIN AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 48 LATIN AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 49 LATIN AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 50 LATIN AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 51 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 52 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 53 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 54 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 55 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 56 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 57 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 58 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 59 DANAHER: MAJOR PRODUCT OFFERINGS
TABLE 60 PERKINELMER: MAJOR PRODUCT OFFERINGS
TABLE 61 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 62 ADVION: MAJOR PRODUCT OFFERINGS
TABLE 63 BGI: MAJOR PRODUCT OFFERINGS
TABLE 64 BIOCRATES LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 65 BRUKER: MAJOR PRODUCT OFFERINGS
TABLE 66 LECO: MAJOR PRODUCT OFFERINGS
TABLE 67 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 68 SCION INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 69 SHIMADZU CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 70 WATERS: MAJOR PRODUCT OFFERINGS
TABLE 71 CREATIVE PROTEOMICS: MAJOR PRODUCT OFFERINGS
TABLE 72 HUMAN METABOLOME TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 73 METABOLON: SERVICE PRODUCT OFFERINGS
TABLE 74 METWARE BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 75 MS-OMICS: MAJOR PRODUCT OFFERINGS
TABLE 76 VPROTEOMICS: MAJOR PRODUCT OFFERINGS
TABLE 77 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 78 GLOBAL METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 79 NORTH AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 80 NORTH AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 81 EUROPE METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 82 EUROPE METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 83 APAC METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 84 APAC METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 85 LATIN AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 86 LATIN AMERICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 87 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 88 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 89 GLOBAL METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 90 GLOBAL METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 91 NORTH AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 92 NORTH AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 93 EUROPE METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 94 EUROPE METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 95 APAC METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 96 APAC METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 97 LATIN AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 98 LATIN AMERICA METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 99 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY APPLICATION 2022–2028 ($ MILLION)
TABLE 100 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY APPLICATION 2022–2028 (%)
TABLE 101 GLOBAL METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 102 GLOBAL METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 103 NORTH AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 104 NORTH AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 105 EUROPE METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 106 EUROPE METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 107 APAC METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 108 APAC METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 109 LATIN AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 110 LATIN AMERICA METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 111 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY END-USER 2022–2028 ($ MILLION)
TABLE 112 MIDDLE EAST & AFRICA METABOLOMICS MARKET BY END-USER 2022–2028 (%)
TABLE 113 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 114 GLOBAL METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 115 GLOBAL DETECTION METHODS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 116 GLOBAL DETECTION METHODS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 117 GLOBAL SEPARATION METHODS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 118 GLOBAL SEPARATION METHODS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 119 GLOBAL BIOINFORMATICS TOOLS & SERVICES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 120 GLOBAL BIOINFORMATICS TOOLS & SERVICES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 121 GLOBAL MEDICAL & CLINICAL RESEARCH METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 122 GLOBAL MEDICAL & CLINICAL RESEARCH METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 123 GLOBAL PLANT & FOOD SCIENCE METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 124 GLOBAL PLANT & FOOD SCIENCE METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 125 GLOBAL BIOTECHNOLOGY METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 126 GLOBAL BIOTECHNOLOGY METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 127 GLOBAL STANDALONE METABOLOMICS SERVICE PROVIDERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 128 GLOBAL STANDALONE METABOLOMICS SERVICE PROVIDERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 129 GLOBAL PHARMA & BIOTECH COMPANIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 130 GLOBAL PHARMA & BIOTECH COMPANIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 131 GLOBAL RESEARCH & CLINICAL LABORATORIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 132 GLOBAL RESEARCH & CLINICAL LABORATORIES METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 133 GLOBAL OTHERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 134 GLOBAL OTHERS METABOLOMICS MARKET BY GEOGRAPHY 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
